ConductScience.org, home

Trial · NCT07882342

Neonatal Thrombocytopenia in the NICU

NCT07882342, Not yet recruiting, Assiut University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Neonatal Thrombocytopenia in the NICU. Trials, record NCT07882342. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882342

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Neonatal Thrombocytopenia in the NICU
NCT number
NCT07882342
Status
Not yet recruiting
Enrollment
120 participants, estimated
Lead sponsor
Assiut University
Conditions
Thrombocytopenia, Neonatal Thrombocytopenia
First posted
2026-10-20
Last updated
2026-10-20

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryFrequency of severe thrombocytopeniaBaselinePercentage of neonates with platelet count less than 50 × 10⁹/L among those with thrombocytopenia.
SecondaryFrequency of early-onset thrombocytopeniaBaselinePercentage of neonates with thrombocytopenia diagnosed within the first 72 hours of life.
SecondaryNumber of neonates requiring platelet transfusionAt 28 daysNumber of neonates who receive one or more platelet transfusions during admission.
SecondaryNumber of neonates with intracranial hemorrhageAt 28 daysNumber of neonates diagnosed with intracranial hemorrhage on cranial ultrasound.
SecondaryMortality rateAt 28 daysNumber of neonates who die during hospital admission.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07882342

GET https://conductscience.org/api/trials/v1/NCT07882342/registered